Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosis.
Nick BansbackJudy A ChiuRebecca MetcalfeEmmanuelle LapointeAlice SchabasMarilyn LenzenAnthony TraboulseeLarry D LyndRobert CarruthersPublished in: Multiple sclerosis journal - experimental, translational and clinical (2021)
This pilot study suggests that PtDA use helps RRMS patients and their clinician select a DMT. Future studies will assess the feasibility of implementation and the impact of the PtDA on timely DMT initiation and longer-term adherence.